Frequency of IL-10-producing regulatory B cells associated with disease activity in thyroid-associated orbitopathy

about

Frequency of IL-10-producing regulatory B cells associated with disease activity in thyroid-associated orbitopathy

Item

http://www.wikidata.org/entity/Q58728114

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Frequency of IL-10-producing r ...... thyroid-associated orbitopathy

@en

Frequency of IL-10-producing r ...... thyroid-associated orbitopathy

@nl

type

Item

label

Frequency of IL-10-producing r ...... thyroid-associated orbitopathy

@en

Frequency of IL-10-producing r ...... thyroid-associated orbitopathy

@nl

prefLabel

Frequency of IL-10-producing r ...... thyroid-associated orbitopathy

@en

Frequency of IL-10-producing r ...... thyroid-associated orbitopathy

@nl

P1476

Frequency of IL-10-producing r ...... thyroid-associated orbitopathy

@en

P2093

Guo Chen

http://www.w3.org/2001/XMLSchema#string

Hua-Sheng Yang

http://www.w3.org/2001/XMLSchema#string

Lai Wei

http://www.w3.org/2001/XMLSchema#string

Qian Li

http://www.w3.org/2001/XMLSchema#string

Xiao-Feng Wen

http://www.w3.org/2001/XMLSchema#string

Yun-Gang Ding

http://www.w3.org/2001/XMLSchema#string

P2860

Rituximab for thyroid-associated ophthalmopathy

Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management

Graves' ophthalmopathy

Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab

CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.

Prevention of arthritis by interleukin 10-producing B cells.

Regulatory B cells: origin, phenotype, and function.

Decrease in proportion of CD19+ CD24(hi) CD27+ B cells and impairment of their suppressive function in Graves' disease.

P304

1458-1462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18240/IJO.2018.09.05

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30225218

http://www.w3.org/2001/XMLSchema#string

P932

6133891

http://www.w3.org/2001/XMLSchema#string